Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|January 22, 2021
Methods to Study the Transcriptome of Regulatory B CellsMaud Maho-Vaillant, Sebastien Calbo
European Journal of Immunology|September 3, 2010
IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitroJean-David Bouaziz, Sebastien Calbo, Maud Maho-Vaillant, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2026
Incidence of P200 pemphigoid: A nationwide studyFabienne Jouen, Marion Carrette, Marie-Laure Golinski, et al.
Frontiers in Immunology|March 12, 2020
CD11c+ B Cells Are Mainly Memory Cells, Precursors of Antibody Secreting Cells in Healthy DonorsMarie-Laure Golinski, Mélanie Demeules, Céline Derambure, et al.
JAMA Dermatology|June 22, 2022
Evaluation of Clinical Relevance and Biological Effects of Antirituximab Antibodies in Patients With PemphigusAlexandre Lemieux, Maud Maho-Vaillant, Marie-Laure Golinski, et al.
Frontiers in Immunology|May 31, 2021
Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid RegimenVivien Hébert, Maud Maho-Vaillant, Marie-Laure Golinski, et al.
The British Journal of Dermatology|June 7, 2024
The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgarisVivien Hébert, Julien Novarino, Maud Maho-Vaillant, et al.
Frontiers in Immunology|August 24, 2019
Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid RegimenVivien Hébert, Marie Petit, Maud Maho-Vaillant, et al.
Frontiers in Immunology|April 4, 2022
The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With RituximabMarie-Laure Golinski, Alexandre Lemieux, Maud Maho-Vaillant, et al.
The British Journal of Dermatology|February 24, 2025
Prevalence and pathogenic activity of anti-desmocollin-3 antibodies in patients with pemphigus vulgaris and pemphigus foliaceusMaud Maho-Vaillant, Alexandre Lemieux, Christophe Arnoult, et al.
Pageof 3